Streetbeat News

Stock Prices

LUV

Southwest Airlines Co (NYSE:LUV) reported a Q1 fiscal 2024 operating revenue increase of 10.9% Y/Y to $6.33 billion, missing consensus estimates. Adjusted EPS fell to $(0.36), and the company experienced an adjusted operating loss of $(377) million. Despite record passenger numbers, challenges included lower-than-expected leisure passenger volume and Boeing delivery delays. The company announced cost control measures and operational closures at four airports. Q2 guidance anticipates a RASM decrease and increased costs, with LUV shares dropping 9.3%.

Portfolio Pulse from Akanksha Bakshi

April 25, 2024 | 3:14 pm

NEM

Newmont Corporation announced in a conference call that its Q2 production and costs are expected to remain consistent with Q1 levels. This update provides investors with insights into the company's operational stability and financial outlook.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 3:11 pm

INDV

Indivior shares are trading lower following the company's report of worse-than-expected Q1 earnings per share (EPS) and sales.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 3:06 pm

ATNI

ATN International shares dropped following a report of disappointing Q1 revenue results and a reduction in FY24 revenue guidance below expectations.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 3:06 pm

KEX

Kirby Corporation's shares surged following the announcement of their Q1 earnings per share (EPS) and sales figures, which exceeded analysts' expectations.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 3:05 pm

TRYPF

Tryp Therapeutics Inc. (OTCQB:TRYPF) has received approval from Exopharm Limited shareholders for a merger, creating Tryptamine Therapeutics Limited. The merger, valued at CA$12.8 million, offers Tryp shareholders a significant premium, with Exopharm issuing 4.52 shares for each Tryp share. Trading of Tryp shares will halt on April 29, 2024, ahead of the ASX listing under ticker 'TYP' by mid-May 2024. This strategic move aims to enhance shareholder value and expand clinical programs, leveraging Australia's biotech landscape.

Portfolio Pulse from Patricio Liddle

April 25, 2024 | 3:05 pm

CX

Cemex shares are trading lower following the announcement of worse-than-expected Q1 sales results.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 3:04 pm

MC

Moelis & Company's shares traded lower following the announcement that the company missed its Q1 revenue estimates.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 3:04 pm

ETCUSD

Ethereum Classic (CRYPTO: ETC) has seen a 4.45% decrease in price over the last 24 hours, landing at $26.03. This drop is part of a broader negative trend over the past week, with a slight 0.0% loss from $26.11. Despite this, trading volume for ETC has increased by 8.0% over the week, and its circulating supply now stands at 146.73 million, approximately 69.64% of its maximum supply. Ethereum Classic's market cap ranks it 29th at $3.83 billion.

Portfolio Pulse from Benzinga Insights

April 25, 2024 | 3:03 pm

SNAP

A significant options trade was executed for Snap Inc. (SNAP), involving a sweep of 2,000 June 21 $7 puts at $0.141 each, compared to an open interest of 6,288, with SNAP's stock reference price at $10.925.

Portfolio Pulse from Charles Gross

April 25, 2024 | 3:03 pm